Table 1.
Number of proteins identified per condition (2.5 and 50k) and cell type (cMo, iMo, ncMo, MAC, PB T cells, GBM T cells).
| Cell population (cell number) | Number of identified proteins | |||
|---|---|---|---|---|
| Maximum | In all donors | |||
| At least 1 unique pp/protein | ≥2 unique pp/protein | At least 1 unique pp/protein | ≥2 unique pp/protein | |
| cMo (2.5k) | 3,881 | 3,211 | 1,930 | 1,861 |
| cMo (50k) | 3,737 | 3,163 | 2,109 | 2,015 |
| iMo (2.5k) | 3,915 | 3,229 | 2,046 | 1,972 |
| iMo (50k) | 3,995 | 3,288 | 2,069 | 2,069 |
| ncMo (2.5k) | 3,903 | 3,224 | 1,758 | 1,695 |
| ncMo (50k) | 3,902 | 3,225 | 2,198 | 2,095 |
| MAC (2.5k) | 3,599 | 3,076 | 2,481 | 2,332 |
| MAC (50k) | 3,842 | 3,210 | 2,218 | 2,112 |
| PB T cell (2.5k) | 3,837 | 3,208 | 2,078 | 1,998 |
| PB T cell (50k) | 3,902 | 3,225 | 2,198 | 2,095 |
| GBM T cell (2.5k) | 3,600 | 3,075 | 2,430 | 2,293 |
| GBM T cell (50k) | 3,934 | 3,239 | 2,351 | 2,211 |
Maximum refers to proteins identified in any biological replicate, whereas In all donors refers to those proteins systematically detected in all biological replicates.
cMo, classical monocyte; iMo, intermediate monocyte; ncMo, non-classical monocyte; MAC, glioma macrophage/microglia; PB, peripheral blood; GBM, glioblastoma; pp, peptide.